Home Toragen

Toragen

In operation
Seed Round Financing
Cancer Immunotherapy Developer
Basic
Enterprise Profile

Basic Information

Toragen Focuses on Repurposing Antiviral Drugs and Developing New Immunotherapies to Treat Virus-Associated Cancers.
Toragen, Inc.
SanDiego,California,United States of America
15~50 people
January 01, 2016
inquiries@toragen.com

Enterprise Profile

Industrial Sector
New Drug Development CXO (Pharmaceutical Outsourcing Organization)
Technology
Biotechnology
Concept
Tumor
Application Scenarios
Innovative Drugs